Cargando…
TB Mobile: a mobile app for anti-tuberculosis molecules with known targets
BACKGROUND: An increasing number of researchers are focused on strategies for developing inhibitors of Mycobacterium tuberculosis (Mtb) as tuberculosis (TB) drugs. RESULTS: In order to learn from prior work we have collated information on molecules screened versus Mtb and their targets which has bee...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616884/ https://www.ncbi.nlm.nih.gov/pubmed/23497706 http://dx.doi.org/10.1186/1758-2946-5-13 |
_version_ | 1782265181238198272 |
---|---|
author | Ekins, Sean Clark, Alex M Sarker, Malabika |
author_facet | Ekins, Sean Clark, Alex M Sarker, Malabika |
author_sort | Ekins, Sean |
collection | PubMed |
description | BACKGROUND: An increasing number of researchers are focused on strategies for developing inhibitors of Mycobacterium tuberculosis (Mtb) as tuberculosis (TB) drugs. RESULTS: In order to learn from prior work we have collated information on molecules screened versus Mtb and their targets which has been made available in the Collaborative Drug Discovery (CDD) database. This dataset contains published data on target, essentiality, links to PubMed, TBDB, TBCyc (which provides a pathway-based visualization of the entire cellular biochemical network) and human homolog information. The development of mobile cheminformatics apps could lower the barrier to drug discovery and promote collaboration. Therefore we have used this set of over 700 molecules screened versus Mtb and their targets to create a free mobile app (TB Mobile) that displays molecule structures and links to the bioinformatics data. By input of a molecular structures and performing a similarity search within the app we can infer potential targets or search by targets to retrieve compounds known to be active. CONCLUSIONS: TB Mobile may assist researchers as part of their workflow in identifying potential targets for hits generated from phenotypic screening and in prioritizing them for further follow-up. The app is designed to lower the barriers to accessing this information, so that all researchers with an interest in combatting this deadly disease can use it freely to the benefit of their own efforts. |
format | Online Article Text |
id | pubmed-3616884 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-36168842013-04-05 TB Mobile: a mobile app for anti-tuberculosis molecules with known targets Ekins, Sean Clark, Alex M Sarker, Malabika J Cheminform Research Article BACKGROUND: An increasing number of researchers are focused on strategies for developing inhibitors of Mycobacterium tuberculosis (Mtb) as tuberculosis (TB) drugs. RESULTS: In order to learn from prior work we have collated information on molecules screened versus Mtb and their targets which has been made available in the Collaborative Drug Discovery (CDD) database. This dataset contains published data on target, essentiality, links to PubMed, TBDB, TBCyc (which provides a pathway-based visualization of the entire cellular biochemical network) and human homolog information. The development of mobile cheminformatics apps could lower the barrier to drug discovery and promote collaboration. Therefore we have used this set of over 700 molecules screened versus Mtb and their targets to create a free mobile app (TB Mobile) that displays molecule structures and links to the bioinformatics data. By input of a molecular structures and performing a similarity search within the app we can infer potential targets or search by targets to retrieve compounds known to be active. CONCLUSIONS: TB Mobile may assist researchers as part of their workflow in identifying potential targets for hits generated from phenotypic screening and in prioritizing them for further follow-up. The app is designed to lower the barriers to accessing this information, so that all researchers with an interest in combatting this deadly disease can use it freely to the benefit of their own efforts. BioMed Central 2013-03-06 /pmc/articles/PMC3616884/ /pubmed/23497706 http://dx.doi.org/10.1186/1758-2946-5-13 Text en Copyright © 2013 Ekins et al.; licensee Chemistry Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Ekins, Sean Clark, Alex M Sarker, Malabika TB Mobile: a mobile app for anti-tuberculosis molecules with known targets |
title | TB Mobile: a mobile app for anti-tuberculosis molecules with known targets |
title_full | TB Mobile: a mobile app for anti-tuberculosis molecules with known targets |
title_fullStr | TB Mobile: a mobile app for anti-tuberculosis molecules with known targets |
title_full_unstemmed | TB Mobile: a mobile app for anti-tuberculosis molecules with known targets |
title_short | TB Mobile: a mobile app for anti-tuberculosis molecules with known targets |
title_sort | tb mobile: a mobile app for anti-tuberculosis molecules with known targets |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616884/ https://www.ncbi.nlm.nih.gov/pubmed/23497706 http://dx.doi.org/10.1186/1758-2946-5-13 |
work_keys_str_mv | AT ekinssean tbmobileamobileappforantituberculosismoleculeswithknowntargets AT clarkalexm tbmobileamobileappforantituberculosismoleculeswithknowntargets AT sarkermalabika tbmobileamobileappforantituberculosismoleculeswithknowntargets |